jrnl8069

Publication Venue For

  • Response by G. Howard and V.J. Howard to Letter Regarding Article, "Twenty Years of Progress Toward Understanding the Stroke Belt"..  STROKEAHA120029633. 2020
  • Depressive Symptoms After Ischemic Stroke: Population-Based Comparisons of Patients and Caregivers With Matched Controls.  51:54-60. 2020
  • Electrocardiographic ST-T Abnormities Are Associated with Stroke Risk in the REGARDS Study.  1100-1106. 2020
  • Ischemic Stroke due to Blunt Traumatic Cerebrovascular Injury.  51:353-360. 2020
  • Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage.  1142-1149. 2020
  • Twenty years of progress toward understanding the stroke belt.  742-750. 2020
  • Associations between left ventricular structure, function, and cerebral amyloid the ARIC-PET study.  50:3622-3624. 2019
  • Associations of perioperative variables with the 30-day risk of stroke or death in carotid endarterectomy for symptomatic carotid stenosis.  50:3439-3448. 2019
  • Neighborhood Socioeconomic Status and Trajectories of Physical Health-Related Quality of Life Among Stroke Survivors.  50:3191-3197. 2019
  • Advice From Prior Fellows to Current Fellows on Preparation for Transition to Junior Attending..  50:e250-e252. 2019
  • Differential Impact of Risk Factors on Stroke Occurrence Among Men Versus Women in West Africa: The SIREN Study.  50:820-827. 2019
  • Sociodemographic Disparities in Long-Term Mortality Among Stroke Survivors in the United States: The REGARDS Study.  50:805-812. 2019
  • Safety of Carotid Revascularization in Patients with a History of Coronary Heart Disease.  50:413-418. 2019
  • Response by Liberman et al to Letter Regarding Article, "Misdiagnosis of Cerebral Vein Thrombosis in the Emergency Department".  49:e280. 2018
  • Risk factors for poststroke cognitive decline: The REGARDS study (reasons for geographic and racial differences in stroke).  49:987-994. 2018
  • Advances in stroke 2017.  49:E174-E199. 2018
  • Arsenic exposure in relation to ischemic stroke the reasons for geographic and racial differences in stroke study.  49:19-26. 2018
  • Challenge and yield of enrolling racially and ethnically diverse patient populations in low event rate clinical trials.  49:84-89. 2018
  • Exome chip analysis identifies low-frequency and rare variants in MRPL38 for white matter hyperintensities on brain magnetic resonance imaging.  49:1812-1819. 2018
  • Immediate and delayed procedural stroke or death in stenting versus endarterectomy for symptomatic carotid stenosis.  49:2715-2722. 2018
  • Impact of conventional stroke risk factors on stroke in women an update.  49:536-542. 2018
  • Misdiagnosis of cerebral vein thrombosis in the emergency department.  49:1504-1506. 2018
  • Prediction models for clinical outcome after a carotid revascularization procedure an external validation study.  49:1880-1885. 2018
  • Baseline quality of life and risk of stroke in the ALLHAT study (antihypertensive and lipid-lowering treatment to prevent heart attack trial).  48:3078-3085. 2017
  • Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association.  48:e284-e303. 2017
  • Factors Associated with Time to Site Activation, Randomization, and Enrollment Performance in a Stroke Prevention Trial.  48:2511-2518. 2017
  • Contributors to the Excess Stroke Mortality in Rural Areas in the United States.  48:1773-1778. 2017
  • Predicting Domain-Specific Health-Related Quality of Life Using Acute Infarct Volume.  48:1925-1931. 2017
  • Self-Reported Stroke Risk Stratification.  48:1737-1743. 2017
  • Early Endarterectomy Carries a Lower Procedural Risk Than Early Stenting in Patients with Symptomatic Stenosis of the Internal Carotid Artery: Results from 4 Randomized Controlled Trials.  48:1580-1587. 2017
  • Stroke in Indigenous Africans, African Americans, and European Americans: Interplay of Racial and Geographic Factors.  48:1169-1175. 2017
  • Use of Platelet Function Testing before Pipeline Embolization Device Placement: A Multicenter Cohort Study.  48:1322-1330. 2017
  • Ischemic Stroke after Treatment of Intraprocedural Thrombosis during Stent-Assisted Coiling and Flow Diversion.  48:1098-1100. 2017
  • Stroke Recovery and Rehabilitation Research: Issues, Opportunities, and the National Institutes of Health StrokeNet.  48:813-819. 2017
  • Response by Gutiérrez et al to letter regarding article, "Hemoglobin concentration and risk of incident stroke in community-living adults".  47:e260. 2016
  • Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials.  47:2373-2379. 2016
  • Hemoglobin Concentration and Risk of Incident Stroke in Community-Living Adults.  47:2017-2024. 2016
  • Where to focus efforts to reduce the black-white disparity in stroke mortality: Incidence versus case fatality?.  47:1893-1898. 2016
  • Multilingual validation of the questionnaire for verifying stroke-free status in West Africa.  47:167-172. 2016
  • Guidelines for the Management of Patients With Unruptured Intracranial Aneurysms: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.  46:2368-2400. 2015
  • Temporal Changes in Periprocedural Events in the Carotid Revascularization Endarterectomy Versus Stenting Trial.  46:2183-2189. 2015
  • Adherence to a Mediterranean diet and prediction of incident stroke.  46:780-785. 2015
  • Effect of patching on reducing restenosis in the Carotid Revascularization Endarterectomy versus Stenting Trial.  46:757-761. 2015
  • Fibroblast growth factor 23 and risk of incident stroke in community-living adults.  46:322-328. 2015
  • Diet and Stroke: Recent Evidence Supporting a Mediterranean-Style Diet and Food in the Primary Prevention of Stroke.  46:2007-2011. 2015
  • Is Blood Pressure Control for Stroke Prevention the Correct Goal?: The Lost Opportunity of Preventing Hypertension.  46:1595-1600. 2015
  • Mediators of the age effect in the carotid revascularization endarterectomy versus stenting trial (CREST).  46:2868-2873. 2015
  • Myeloperoxidase Is Increased in Human Cerebral Aneurysms and Increases Formation and Rupture of Cerebral Aneurysms in Mice.  46:1651-1656. 2015
  • Physical Activity in Primary Stroke Prevention: Just Do It!.  46:1735-1739. 2015
  • Premature Ventricular Complexes on Screening Electrocardiogram and Risk of Ischemic Stroke.  46:1365-1367. 2015
  • Rapid assessment and treatment of transient ischemic attacks and minor stroke in Canadian emergency departments: Time for a paradigm shift.  46:2987-2990. 2015
  • Response to Letter Regarding Article, "fibroblast Growth Factor 23 and Risk of Incident Stroke in Community-Living Adults".  46:e124. 2015
  • Summary of evidence on early carotid intervention for recently symptomatic stenosis based on meta-analysis of current risks.  46:3423-3436. 2015
  • Time from symptoms to carotid endarterectomy or stenting and perioperative risk.  46:3540-3542. 2015
  • Common caregiver issues following a stroke 2014
  • Advances in stroke population studies 2013.  45:368-370. 2014
  • Assessing the performance of the framingham stroke risk score in the reasons for geographic and racial differences in stroke cohort.  45:1716-1720. 2014
  • Common caregiver issues and nursing interventions after a stroke.  45. 2014
  • Complication rates and center enrollment volume in the carotid revascularization endarterectomy versus stenting trial.  45:3320-3324. 2014
  • Factors influencing the decline in stroke mortality a statement from the american heart association/american stroke association.  45:315-353. 2014
  • Guidelines for the prevention of stroke in women: A statement for healthcare professionals from the American heart association/American stroke association.  45:1545-1588. 2014
  • N-terminal pro-B-type natriuretic peptide and stroke risk: The reasons for geographic and racial differences in stroke cohort.  45:1646-1650. 2014
  • Picking the good apples: Statistics versus good judgment in choosing stent operators for a multicenter clinical trial.  45:3325-3329. 2014
  • Racial differences in the association of insulin resistance with stroke risk: The REasons for Geographic and Racial Differences in Stroke (REGARDS) study.  45:2257-2262. 2014
  • Risk adjustment of ischemic stroke outcomes for comparing hospital performance a statement for healthcare professionals from the american heart association/american stroke association.  45:918-944. 2014
  • Six-minute magnetic resonance imaging protocol for evaluation of acute ischemic stroke: Pushing the boundaries.  45:1985-1991. 2014
  • Dietary patterns are associated with incident stroke and contribute to excess risk of stroke in black americans.  44:3305-3311. 2013
  • Ancel keys lecture adventures (and misadventures) in understanding (and reducing) disparities in stroke mortality.  44:3254-3259. 2013
  • Physical activity frequency and risk of incident stroke in a National US study of blacks and whites.  44:2519-2524. 2013
  • Systemic inflammatory response syndrome in tissue-type plasminogen activator-treated patients is associated with worse short-term functional outcome.  44:2321-2323. 2013
  • Disparities in evaluation at certified primary stroke centers: Reasons for geographic and racial differences in stroke.  44:1930-1935. 2013
  • Life's simple 7 and risk of incident stroke: The reasons for geographic and racial differences in stroke study.  44:1909-1914. 2013
  • Method for enhancing real-world use of a more affected arm in chronic stroke: Transfer package of constraint-induced movement therapy.  44:1383-1388. 2013
  • Risk factors for intracerebral hemorrhage: The reasons for geographic and racial differences in stroke (REGARDS) study.  44:1282-1287. 2013
  • Real-time validation of transcranial doppler criteria in assessing recanalization during intra-arterial procedures for acute ischemic stroke an international, multicenter study.  44:394-400. 2013
  • Forecasting the future of stroke in the united states: A policy statement from the American heart association and American stroke association.  44:2361-2375. 2013
  • Reasons underlying racial differences in stroke incidence and mortality.  44. 2013
  • Self-report of stroke, transient ischemic attack, or stroke symptoms and risk of future stroke in the reasons for geographic and racial differences in stroke (REGARDS) study.  44:55-60. 2013
  • The current state and future of stroke: Introduction.  44. 2013
  • Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS).  43:2682-2688. 2012
  • How do we know if we are making progress in reducing the public health burden of stroke?.  43:2033-2034. 2012
  • Response to letter regarding article entitled "a simple, assumption-free, and clinically interpretable approach for analysis of modified rankin outcomes".  43. 2012
  • Association between family risk of stroke and myocardial infarction with prevalent risk factors and coexisting diseases.  43:974-979. 2012
  • Statistical analysis of the primary outcome in acute stroke trials.  43:1171-1178. 2012
  • A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes.  43:664-669. 2012
  • Advances in stroke: Population studies.  43:305-307. 2012
  • Atrophy of spared gray matter tissue predicts poorer motor recovery and rehabilitation response in chronic stroke.  43:453-457. 2012
  • Age and outcomes after carotid stenting and endarterectomy: The Carotid Revascularization Endarterectomy Versus Stenting Trial.  42:3484-3490. 2011
  • Traditional risk factors as the underlying cause of racial disparities in stroke: Lessons from the half-full (empty?) glass.  42:3369-3375. 2011
  • Velocity criteria for intracranial stenosis revisited: An international multicenter study of transcranial Doppler and digital subtraction angiography.  42:3429-3434. 2011
  • Self-reported stroke symptoms without a prior diagnosis of stroke or transient ischemic attack: A powerful new risk factor for stroke.  42:3122-3126. 2011
  • Self-reported atrial fibrillation and risk of stroke in the reasons for geographic and racial differences in stroke (REGARDS) study.  42:2950-2953. 2011
  • Simplified modified rankin scale questionnaire: Reproducibility over the telephone and validation with quality of life.  42:2276-2279. 2011
  • Racial-ethnic disparities in stroke care: The American experience: A statement for healthcare professionals from the American Heart Association/American Stroke Association.  42:2091-2116. 2011
  • Wisdom and determination in the ongoing pursuit of the ever-elusive neuroprotective agent.  42:1505-1506. 2011
  • Safety and tolerability of early noninvasive ventilatory correction using bilevel positive airway pressure in acute ischemic stroke.  42:1030-1034. 2011
  • Age and Outcomes following Stenting compared to Endarterectomy: The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST).  42:E46-E46. 2011
  • Albuminuria, Kidney Function and Risk of Stroke in the REGARDS Cohort.  42:E192-E193. 2011
  • Could Racial Differences In Susceptibility To Elevated Blood Pressures Contribute To The Excess Stroke Mortality In Blacks: The Reasons For Geographic And Racial Differences In Stroke (REGARDS) Study?.  42:E49-E49. 2011
  • Do Demographic Disparities in Neuroimaging Utilization Exist in Stroke? The REGARDS Experience.  42:E130-E130. 2011
  • Effect of Diabetes (DM) on Ischemic Stroke Incidence and Case Fatality.  42:E116-E117. 2011
  • Effects of exercise on quality of life in stroke survivors: A meta-analysis.  42:832-837. 2011
  • Geographic Disparities in Elevated Blood Pressures, but Not Resistant Hypertension in Southeast: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort.  42:E49-E49. 2011
  • Health-Related Quality of Life after Carotid Stenting versus Carotid Endarterectomy: Results from the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST).  42:E78-E78. 2011
  • Lower Executive Function Increases Risk For Incident Stroke in the National REGARDS Cohort.  42:E55-E56. 2011
  • Predictors of Short Term Clinical Outcome Following Stroke in the Young: Data from a Tertiary Care Center in the US "Stroke Belt".  42:E274-E274. 2011
  • Prevalence and Significance of Unrecognized Myocardial Infarctions with Stroke Risk: The REGARDS Study.  42:E102-E102. 2011
  • Race and gender differences in 1-year outcomes for community-dwelling stroke survivors with family caregivers.  42:626-631. 2011
  • Risk Of Stroke Following Self-report Of Stroke, Tia Or Stroke Symptoms In The Regards Study.  42:E195-E195. 2011
  • Safety of Carotid Stenting and Endarterectomy in Symptomatic and Asymptomatic Patients: Results from the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST).  42:E45-E45. 2011
  • Self-Reported Stroke Symptoms Without a Prior Diagnosis of Stroke or TIA: A Powerful New Risk Factor for Stroke.  42:E103-E104. 2011
  • Stroke Risk in Persons with Heart Failure: The REGARDS Study.  42:E271-E271. 2011
  • Subclinical Stroke Symptoms and Diabetes in the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study.  42:E273-E274. 2011
  • Guidelines for the primary prevention of stroke: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association.  42:517-584. 2011
  • Pumps, aqueducts, and drought management: Vascular physiology in vascular cognitive impairment.  42:221-226. 2011
  • Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).  42:675-680. 2011
  • The EXCITE stroke trial: Comparing early and delayed constraint-induced movement therapy.  41:2309-2315. 2010
  • Improvement in aphasia scores after stroke is well predicted by initial severity.  41:1485-1488. 2010
  • Improving modified rankin scale assessment with a simplified questionnaire.  41:1048-1050. 2010
  • Diagnostic criteria and yield of real-time transcranial doppler monitoring of intra-arterial reperfusion procedures.  41:695-699. 2010
  • Racial Disparities in Awareness and Treatment of Atrial Fibrillation: The Reasons for Geographic and Racial Differences in Stroke Study.  41:E245-E245. 2010
  • Racial disparities in awareness and treatment of atrial fibrillation: The REasons for geographic and racial differences in stroke (REGARDS) study.  41:581-587. 2010
  • Stroke Incidence as the Major Contributor to Racial and Regional Disparities in Stroke Mortality: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.  41:E244-E245. 2010
  • Traditional Risk Factors Play a Minor Role in the Excess Stroke Incidence of African Americans: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study.  41:E225-E225. 2010
  • Caregiving strain and estimated risk for stroke and coronary heart disease among spouse caregivers: Differential effects by race and sex.  41:331-336. 2010
  • Ancrod in acute ischemic stroke: Results of 500 subjects beginning treatment within 6 hours of stroke onset in the ancrod stroke program.  40:3796-3803. 2009
  • Blood pressure and stroke in heart failure in the reasons for geographic and racial differences in stroke (regards) study.  40:3706-3710. 2009
  • Recommendations for imaging of acute ischemic stroke: A scientific statement from the american heart association.  40:3646-3678. 2009
  • Improvement after constraint-induced movement therapy is independent of infarct location in chronic stroke patients.  40:2468-2472. 2009
  • Sample size estimates for clinical trials of vasospasm in subarachnoid hemorrhage.  40:2362-2367. 2009
  • Elderly Women Have Lower Rates of Stroke, Cardiovascular Events, and Mortality After Hospitalization for Transient Ischemic Attack.  40:2116-2122. 2009
  • Problems and benefits reported by Stroke family caregivers: Results from a prospective epidemiological study.  40:2129-2133. 2009
  • Does sex matter? Thirty-day stroke and death rates after carotid artery stenting in women versus men results from the carotid revascularization endarterectomy versus stenting trial (CREST) lead-in phase.  40:1140-1147. 2009
  • Feasibility of Epidemiology-Driven Multi-Modal Community Stroke Prevention Screening in High Risk African American (AA) Communities.  40:E183-E183. 2009
  • Framingham Stroke Risk by Duration and Age at Exposure to the Stroke Belt..  40:E189-E189. 2009
  • Genomics of human intracranial aneurysm wall.  40:1252-1261. 2009
  • Stroke Symptoms Without Stroke Or Tia Diagnosis Are Associated With Higher Mortality.  40:E187-E187. 2009
  • High-risk populations introduction.  40. 2009
  • Regional differences in diabetes as a possible contributor to the geographic disparity in stroke mortality: The REasons for geographic and racial differences in stroke study.  39:1675-1680. 2008
  • Assessing the impact of vascular disease in demented and nondemented patients.  39:783-784. 2008
  • Linking MRI hyperintensities with patterns of neuropsychological impairment: Evidence for a threshold effect.  39:806-813. 2008
  • Advances in population studies 2007.  39:283-285. 2008
  • Association between increased diastolic blood pressure levels and cognitive impairment: the reasons for geographic and racial differences in stroke (REGARDS) study..  39:544-544. 2008
  • Closure of the lead-in phase of CREST (carotid revascularization endarterectomy vs. stenting trial): 30-day and one year analyses.  39:557-557. 2008
  • Does differential prophylactic aspirin use contribute to racial and geographic disparities in stroke?.  39:556-556. 2008
  • Inadequate awareness and control of vascular risk factors in stroke patients: The REasons for geographic and racial differences in stroke (REGARDS) study.  39:630-630. 2008
  • Stroke risk factors are predictive of cognitive decline in the absence of clinically diagnosed incident stroke.  39:559-559. 2008
  • Remodeling the brain: plastic structural brain changes produced by different motor therapies after stroke..  39:1520-1525. 2008
  • The importance of epidemiological studies should not be downplayed.  39:1-2. 2008
  • Stroke symptoms in individuals reporting no prior stroke or transient ischemic attack are associated with a decrease in indices of mental and physical functioning.  38:2446-2452. 2007
  • From sea to shining sea: What is it about where you live and your stroke risk?.  38:2210-2212. 2007
  • Reduced medication access: A marker for vulnerability in US stroke survivors.  38:1557-1564. 2007
  • Cognitive status, stroke symptom reports, and modifiable risk factors among individuals with no diagnosis of stroke or transient ischemic attack in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.  38:1143-1147. 2007
  • Factors associated with care-seeking behavior in response to stroke symptoms: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.  38:528-528. 2007
  • Nonconventional clinical trial designs: Approaches to provide more precise estimates of treatment effects with a smaller sample size, but at a cost.  38:804-808. 2007
  • Periprocedural hemorrhagic and hemodynamic events are associated with increased risk in carotid artery stenting: The carotid revascularization endarterectomy vs stenting trial (CREST).  38:483-483. 2007
  • Racial and geographic differences in prevalence, awareness, treatment, and control of dyslipidemia: The REasons for Geographic and Racial Differences in Stroke (REGARDS) study.  38:533-533. 2007
  • Recommendations from the STAIR V meeting on acute stroke trials, technology and outcomes.  38:245-248. 2007
  • Reduced medication access: A marker for vulnerability in US stroke survivors.  38:479-479. 2007
  • Stroke symptoms in individuals reporting no prior stroke or TIA are associated with a decrease in indices of mental and physical functioning.  38:482-482. 2007
  • The association between family risk of stroke and family risk of heart attack with prevalent risk factors and coexisting diseases: Challenges for the understanding of the genetics of stroke and heart disease.  38:528-528. 2007
  • Primary prevention of ischemic stroke. A guideline from the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council.  37:1583-1633. 2006
  • Racial and geographic differences in awareness, treatment, and control of hypertension: The REasons for geographic and racial differences in stroke study.  37:1171-1178. 2006
  • A placebo-controlled trial of constraint-induced movement therapy for upper extremity after stroke.  37:1045-1049. 2006
  • 1-year restenosis after carotid stenting in the lead-in phase of the Carotid Revascularization Endarterectomy vs Stenting Trial (CREST).  37:620-620. 2006
  • Impaired cognitive screening status is associated with stroke symptom reports and modifiable health-related behaviors after controlling for age, education, ethnicity, and regional variation in stroke risk.  37:673-673. 2006
  • Socioeconomic status and control of stroke risk factors: The reasons for geographic and racial differences in stroke study.  37:668-668. 2006
  • Reliability and validity of the upper-extremity motor activity log-14 for measuring real-world arm use.  36:2493-2496. 2005
  • Is Bayesian analysis ready for use in phase III randomized clinical trials? Beware the sound of the sirens.  36:1622-1623. 2005
  • Is Bayesian analysis ready for use in phase III randomized clinical trials? Beware the sound of the sirens.  36:1622-1623. 2005
  • Recommendations for comprehensive stroke centers: A consensus statement from the brain attack coalition.  36:1597-1616. 2005
  • AutoCITE: Automated delivery of CI therapy with reduced effort by therapists.  36:1301-1304. 2005
  • Regional differences in the increased stroke mortality of African Americans: The remarkable stroke burden of being a Southern African American.  36:427-427. 2005
  • Targets for vascular protection after acute ischemic stroke.  35:2220-2225. 2004
  • Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: A case-control study.  35:1360-1363. 2004
  • Does the stroke risk of stenting increase at older ages? Thirty-day stroke-death rates in the CREST lead-in phase.  35:258-258. 2004
  • Gender and periprocedural stroke and death following carotid artery stenting: Results from the CREST lead-in phase.  35:253-253. 2004
  • Timing of cerebrovascular events in CREST lead-in patients.  35:254-254. 2004
  • Identifying Risk Factors for Perioperative Outcomes After Carotid Endarterectomy: The Story Continues.  34:2573-2575. 2003
  • Efficacy and tolerability of donepezil in vascular dementia: Positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.  34:2323-2330. 2003
  • Measurement of cognitive deficits in acute stroke.  34:2396-2398. 2003
  • Monitoring of cerebral vasodilatory capacity with transcranial Doppler carbon dioxide inhalation in patients with severe carotid artery disease.  34:945-949. 2003
  • Midazolam challenge reinduces neurological deficits after transient ischemic attack.  34:794-796. 2003
  • Racial differences in thoracic aorta atherosclerosis among ischemic stroke patients.  34:408-412. 2003
  • Re: Telephone intervention with family caregivers of stroke survivors after rehabilitation [6] (multiple letters).  34:7-8. 2003
  • Telephone intervention with family caregivers of stroke survivors after rehabilitation.  33:2060-2065. 2002
  • Practice makes perfect..  33:1856. 2002
  • Genetic and environmental risk factors for intracerebral hemorrhage: Preliminary results of a population-based study.  33:1190-1195. 2002
  • Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood institute Family Heart Study.  33:1357-1361. 2002
  • Changes in plasma homocyst(e)ine in the acute phase after stroke.  33:473-478. 2002
  • Reemergence of stroke deficits with midazolam challenge.  33:283-285. 2002
  • Geographic differences in the magnitude of the African American excess risk of stroke death.  33:391-391. 2002
  • Decline in US stroke mortality an analysis of temporal patterns by sex, race, and geographic region.  32:2213-2218. 2001
  • Intrathecal baclofen for spastic hypertonia from stroke.  32:2099-2107. 2001
  • Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria.  32:1091-1096. 2001
  • Effect of contralateral occlusion on long-term efficacy of endarterectomy in the Asymptomatic Carotid Atherosclerosis Study (ACAS) [5] (multiple letters).  32:1447-1448. 2001
  • Effect of contralateral occlusion on long-term efficacy of endarterectomy in the Asymptomatic Carotid Atherosclerosis Study (ACAS) - Response.  32:1448-1448. 2001
  • Constraint-induced therapy of chronic aphasia after stroke.  32:1621-1626. 2001
  • Parallel hypothesis testing for science and industry in a large randomized clinical trial.  32:328-328. 2001
  • Primary prevention of ischemic stroke: A statement for healthcare professionals from the stroke council of the American Heart Association.  32:280-299. 2001
  • Stability of plasma homocyst(e)ine in acute stroke patients (SHASP).  32:361-361. 2001
  • The decline in stroke mortality: an analysis of temporal patterns by sex, race and geographic region.  32:320-320. 2001
  • Anticoagulant patient information material is written at high readability levels.  31:2966-2970. 2000
  • Depression and other determinants of values placed on current health state by stroke patients: Evidence from the VA acute stroke (VASt) study.  31:2603-2609. 2000
  • Effect of contralateral occlusion on long-term efficacy of endarterectomy in the Asymptomatic Carotid Atherosclerosis Study (ACAS).  31:2330-2334. 2000
  • Evolution of cortical activation during recovery from corticospinal tract infarction.  31:656-661. 2000
  • Objective measurement of functional upper-extremity movement using accelerometer recordings transformed with a threshold filter.  31:662-667. 2000
  • Racial variation in initial stroke severity.  31:563-567. 2000
  • Treatment-induced cortical reorganization after stroke in humans.  31:1210-1216. 2000
  • Effects of constraint-induced movement therapy on patients with chronic motor deficits after stroke: A replication.  30:586-592. 1999
  • Geographic variations in major stroke risk factors.  30:255-255. 1999
  • Stroke incidence and survival among middle-aged adults: 9-Year follow- up of the Atherosclerosis Risk in Communities (ARIC) cohort.  30:736-743. 1999
  • The effect of contralateral occlusion on peri-operative and late stroke rates in the asymptomatic carotid atherosclerosis study (ACAS).  30:242-242. 1999
  • Carotid stenting and angioplasty: a statement for healthcare professionals from the Councils on Cardiovascular Radiology, Stroke, Cardio-Thoracic and Vascular Surgery, Epidemiology and Prevention, and Clinical Cardiology, American Heart Association..  29:336-338. 1998
  • Cigarette smoking and other risk factors for silent cerebral infarction in the general population.  29:913-917. 1998
  • Increased workload enhances force output during pedaling exercise in persons with poststroke hemiplegia.  29:598-606. 1998
  • Recurrent carotid stenosis: Results of the asymptomatic carotid atherosclerosis study.  29:2018-2025. 1998
  • Does the Association of Risk Factors and Atherosclerosis Change With Age?.  28:1693-1701. 1997
  • Cigarette smoking and silent cerebral infarctions in the general population.  28:92-92. 1997
  • Consistency of Doppler parameters in predicting arteriographically confirmed carotid stenosis.  28:343-347. 1997
  • Does the association of risk factors and atherosclerosis change with age? An analysis of the combined ARIC and CHS cohorts.  28:1693-1701. 1997
  • Evaluation of social status as a contributing factor to the stroke belt region of the United States.  28:936-940. 1997
  • Familial history of stroke and stroke risk: The Family Heart Study.  28:1908-1912. 1997
  • Family history of stroke and MRI abnormalities: The ARIC study.  28:175-175. 1997
  • Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction: The TIMI-II pilot and randomized clinical trial combined experience.  28:1107-1114. 1997
  • Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects: The insulin resistance atheroselerosis study (IRAS).  28:1710-1716. 1997
  • An approach for the use of Doppler ultrasound as a screening tool for hemodynamically significant stenosis (despite heterogeneity of Doppler performance). A multicenter experience. Asymptomatic Carotid Atherosclerosis Study Investigators..  27:1951-1957. 1996
  • Successful use of dissimilar Doppler devices as a screening tool for hemodynamically significant stenosis in ACAS.  27:790-790. 1996
  • A new approach to assess geographical patterns in stroke mortality.  27:1-1. 1996
  • An approach for the use of Doppler ultrasound as a screening tool for hemodynamically significant stenosis (despite heterogeneity of Doppler performance): A multicenter experience.  27:1951-1957. 1996
  • Apolipoprotein E polymorphism is associated with segment-specific extracranial carotid artery intima-media thickening.  27:1755-1759. 1996
  • Ethnic differences in carotid wall thickness: The Insulin Resistance Atherosclerosis Study.  27:1744-1749. 1996
  • COMMON CAROTID VOLUME FLOW-RATES CORRELATE TO IPSILATERAL AND CONTRALATERAL INTERNAL CAROTID-ARTERY STENOSIS.  26:727-727. 1995
  • Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: The atherosclerosis risk in communities (aric) study.  26:386-391. 1995
  • Is the stroke belt disappearing?: An analysis of racial, temporal, and age effects.  26:1153-1158. 1995
  • Response: Steal and cerebral arteriovenous malformations.  26:2371-2372. 1995
  • Role of social class in excess black stroke mortality.  26:1759-1763. 1995
  • Steal and cerebral arteriovenous malformations.  26:2371. 1995
  • The end of the stroke belt?: It may be too early to declare victory!.  26:1150-1152. 1995
  • ‘steal’ is an unestablished mechanism for the clinical presentation of cerebral arteriovenous malformations.  26:1215-1220. 1995
  • Relations of intimal-medial thickness among sites within the carotid artery as evaluated by B-mode ultrasound. ARIC Investigators. Atherosclerosis Risk in Communities..  25:1581-1587. 1994
  • Baseline silent cerebral infarction in the Asymptomatic Carotid Atherosclerosis Study..  25:1122-1129. 1994
  • A prospective reevaluation of transient ischemic attacks as a risk factor for death and fatal or nonfatal cardiovascular events.  25:342-345. 1994
  • ETHNIC-DIFFERENCES IN CAROTID-ARTERY INTIMA-MEDIA THICKNESS AMONG NONDIABETICS - BLACKS, HISPANIC WHITES, AND NON-HISPANIC WHITES.  25:251-251. 1994
  • Ethnic differences in stroke mortality between non-hispanic whites, hispanic whites, and blacks the national longitudinal mortality study.  25:2120-2125. 1994
  • Relations of intimal-medial thickness among sites within the carotid artery as evaluated by B-Mode ultrasound.  25:1581-1587. 1994
  • Spatial distribution of carotid intimal-medial.  25:1812-1819. 1994
  • Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound.  24:1297-1304. 1993
  • Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats.  24:2016-2021. 1993
  • Familial aggregation of stroke the framingham study.  24:1366-1371. 1993
  • Nearing the finish line? The asymptomatic Carotid Atherosclerosis Study..  23:1054-1055. 1992
  • Comparison of multicenter study designs for investigation of carotid endarterectomy efficacy.  23:583-593. 1992
  • Nearing the finish line?.  23:1054-1055. 1992
  • Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects.  23:823-828. 1992
  • Selection process for surgeons in the Asymptomatic Carotid Atherosclerosis Study..  22:1353-1357. 1991
  • A MULTICENTER VALIDATION OF DOPPLER ULTRASOUND VERSUS ANGIOGRAM - THE ACAS EXPERIENCE.  22:147-147. 1991
  • Cerebral infarction verified by cranial computed tomography and prognosis for survival following transient ischemic attack.  22:431-436. 1991
  • OBSERVED HETEROGENEITY IN THE DECLINE OF STROKE MORTALITY IN THE UNITED-STATES FROM 1968 TO 1985.  22:126-126. 1991
  • Reevaluation of transient ischemic attacks as a risk factor for early mortality.  22:582-585. 1991
  • Correlation of carotid bruits and carotid atherosclerosis..  21:678-679. 1990
  • A REEVALUATION OF TIA AS A RISK FACTOR FOR EARLY MORTALITY.  21:168-168. 1990
  • Community hospital-based stroke programs in north carolina, oregon, and new york: IV. Stroke diagnosis and its relation to demographics, risk factors, and clinical status after stroke.  21:867-873. 1990
  • Correlation of carotid bruits and carotid atherosclerosis the following is in reply: To the editor.  21:678-679. 1990
  • Changes in survival following stroke in five north carolina counties observed during two different periods.  20:345-350. 1989
  • Correlation of carotid bruits and carotid atherosclerosis detected by b-mode real-time ultrasonography.  20:1331-1335. 1989
  • Original contributions study design for randomized prospective trial of carotid endarterectomy for asymptomatic atherosclerosis.  20:844-849. 1989
  • Declining morbidity and mortality of carotid endarterectomy: The wake forest university medical center experience.  18:823-829. 1987
  • Factors influencing the survival of 451 transient ischemic attack patients.  18:552-557. 1987
  • Risk factors for extracranial carotid artery atherosclerosis.  18:990-996. 1987
  • Community hospital-based stroke programs: North Carolina, Oregon, and New York: I. Goals, objectives, and data collection procedures.  17:276-284. 1986
  • Community hospital-based stroke programs: North Carolina, Oregon, and New York: II. Description of study population.  17:285-293. 1986
  • Community hospital-based stroke programs: North Carolina, Oregon, and New York: III. Factors influencing survival after stroke: Proportional hazards analysis of 4219 patients.  17:294-299. 1986
  • Evaluation of the north carolina stroke care program.  17:382-386. 1986
  • The sex difference in manifestations of carotid bifurcation disease.  17:877-881. 1986
  • Angiographic appearance of carotid occlusion in acute stroke.  11:485-487. 1980
  • Comparison of doppler ultrasonography with arteriography of the carotid artery bifurcation.  11:402-404. 1980
  • Effects of barbiturates on intracranial pressure and amount of mannitol required to control the intracranial pressure.  10:486-487. 1979
  • Effect of aminophylline on cerebral infarction in the Mongolian Gerbil.  9:477-479. 1978
  • Xenon-133 inhalation method for regional cerebral blood flow measurements: Normal values and test-retest results.  9:396-399. 1978